Vyvgart Hytrulo Interactions
There are 382 drugs known to interact with Vyvgart Hytrulo (efgartigimod alfa/hyaluronidase), along with 2 disease interactions. Of the total drug interactions, 45 are major, 246 are moderate, and 91 are minor.
- View all 382 medications that may interact with Vyvgart Hytrulo
- View Vyvgart Hytrulo disease interactions (2)
Most frequently checked interactions
View interaction reports for Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase) and the medicines listed below.
- acetaminophen
- acetaminophen / hydrocodone
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- albuterol
- aspirin
- Benlysta (belimumab)
- CellCept (mycophenolate mofetil)
- gabapentin
- Jardiance (empagliflozin)
- levothyroxine
- Lexapro (escitalopram)
- losartan
- Mestinon (pyridostigmine)
- metformin
- mycophenolate mofetil
- Ozempic (semaglutide)
- prednisone
- Repatha (evolocumab)
- ropinirole
- Rystiggo (rozanolixizumab)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- valacyclovir
- Vascepa (icosapent)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vyvgart (efgartigimod alfa)
Vyvgart Hytrulo disease interactions
There are 2 disease interactions with Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase) which include:
Report options
More about Vyvgart Hytrulo (efgartigimod alfa / hyaluronidase)
- Vyvgart Hytrulo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Soliris
Soliris infusion is used to treat adults with paroxysmal nocturnal hemoglobinuria (PNH), adults and ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Hizentra
Hizentra (immune globulin) is used as a replacement therapy in patients with primary humoral ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Neostigmine
Neostigmine systemic is used for myasthenia gravis, reversal of neuromuscular blockade, reversal of ...
Pyridostigmine
Pyridostigmine systemic is used for dysautonomia, myasthenia gravis, nerve agent pretreatment ...
Azathioprine
Azathioprine systemic is used for atopic dermatitis, autoimmune hepatitis, behcet's disease ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
